{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:49:09Z","timestamp":1774468149011,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.coph.2020.06.007","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T23:59:09Z","timestamp":1596239949000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Heart failure and diabetes: role of ATM"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-8718","authenticated-orcid":false,"given":"Mary C","family":"Wingard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7496-2830","authenticated-orcid":false,"given":"Chad R","family":"Frasier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahipal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2020.06.007_bib0005","first-page":"1","article-title":"National diabetes datistics report","author":"Centers for Disease Control and Prevention USD of H and HS","year":"2017","journal-title":"Centers Dis Control Prev"},{"key":"10.1016\/j.coph.2020.06.007_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10741-018-9685-0","article-title":"The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions","volume":"23","author":"Ofstad","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.coph.2020.06.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-013-9377-8","article-title":"Metabolic dysfunction in diabetic cardiomyopathy","volume":"19","author":"Isfort","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.coph.2020.06.007_sbref0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2020.06.007_bib0025","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.7150\/ijms.10001","article-title":"Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention","volume":"11","author":"Wu","year":"2014","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.coph.2020.06.007_sbref0030","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2020.06.007_sbref0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-41108-1","article-title":"Ataxia-telangiectasia mutated is located in cardiac mitochondria and impacts oxidative phosphorylation","volume":"9","author":"Blignaut","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2020.06.007_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.29245\/2572-9411\/2017\/1.1077","article-title":"Ataxia-telangiectasia mutated kinase: role in myocardial remodeling","volume":"2","author":"Thrasher","year":"2017","journal-title":"J Rare Dis Res Treat"},{"key":"10.1016\/j.coph.2020.06.007_sbref0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/pai.13020","article-title":"Ataxia\u2010telangiectasia: a review of clinical features and molecular pathology","volume":"30","author":"Amirifar","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.coph.2020.06.007_bib0050","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1182\/blood-2012-09-456897","article-title":"Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions","volume":"121","author":"Ambrose","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coph.2020.06.007_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10557-015-6571-z","article-title":"ATM protein kinase signaling, type 2 diabetes and cardiovascular disease","volume":"29","author":"Espach","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.coph.2020.06.007_bib0060","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s004150050438","article-title":"Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia","volume":"246","author":"Hassin-Baer","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.coph.2020.06.007_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tibs.2011.10.002","article-title":"The ATM protein kinase and cellular redox signaling: beyond the DNA damage response","volume":"37","author":"Ditch","year":"2012","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.coph.2020.06.007_bib0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.coph.2020.06.007_bib0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.coph.2020.06.007_bib0080","first-page":"505","article-title":"Immunodeficiency and infections in ataxia-telangiectasia","volume":"144","author":"Nowak-Wegrzyn","year":"2004","journal-title":"Natl Inst Health"},{"key":"10.1016\/j.coph.2020.06.007_bib0085","doi-asserted-by":"crossref","DOI":"10.1111\/cge.12710","article-title":"Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline","volume":"90","author":"van Os","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.coph.2020.06.007_bib0090","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.cellsig.2008.04.011","article-title":"ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells","volume":"20","author":"Halaby","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.coph.2020.06.007_bib0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X12666160606120254","article-title":"Type 2 diabetes and heart failure: challenges and solutions","volume":"12","author":"Thomas","year":"2016","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.coph.2020.06.007_bib0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","article-title":"Insulin signaling and heart failure","volume":"118","author":"Riehle","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2020.06.007_bib0105","first-page":"294","article-title":"On behalf of the American heart association heart failure and transplantation committee of the council on clinical cardiology; council on cardiovascular and stroke nursing; and the heart failure society of America type 2 diabetes mellitus and heart failure","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2020.06.007_bib0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1758-5996-6-12","article-title":"Link between insulin resistance and hypertension: what is the evidence from evolutionary biology?","volume":"6","author":"Zhou","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.coph.2020.06.007_bib0115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/1573399812666150914120529","article-title":"Present insights on cardiomyopathy in diabetic patients","volume":"12","author":"Soares Fel\u00edcio","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.coph.2020.06.007_bib0120","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.biopha.2018.11.086","article-title":"Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate","volume":"109","author":"Al Hroob","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.coph.2020.06.007_bib0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0135-z","article-title":"Cellular death, reactive oxygen species (ROS) and diabetic complications review-Article","volume":"9","author":"Volpe","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.coph.2020.06.007_bib0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/bmjdrc-2018-000529","article-title":"Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes","volume":"6","author":"Zoppini","year":"2018","journal-title":"BMJ Open Diab Res Care"},{"key":"10.1016\/j.coph.2020.06.007_bib0135","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.coph.2020.06.007_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-011-0769-6","article-title":"Ataxia telangiectasia mutated kinase plays a protective role in \u03b2-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling","volume":"353","author":"Foster","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.coph.2020.06.007_bib0145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001286","article-title":"Deficiency of ataxia telangiectasia mutated kinase delays inflammatory response in the heart following myocardial infarction","volume":"3","author":"Daniel","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.coph.2020.06.007_bib0150","article-title":"Lack of ATM induces structural and functional changes in the heart: role in \u03b2-adrenergic receptor-stimulated apoptosis","volume":"94","author":"Foster","year":"2012","journal-title":"Exp Physiol"},{"key":"10.1016\/j.coph.2020.06.007_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083513","article-title":"Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis","volume":"8","author":"Foster","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2020.06.007_sbref0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1152\/ajpheart.00042.2018","article-title":"Ataxia telangiectasia mutated kinase deficiency impairs the autophagic response early during myocardial infarction","volume":"315","author":"Thrasher","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.coph.2020.06.007_sbref0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006349","article-title":"Haplodeficiency of ataxia telangiectasia mutated accelerates heart failure after myocardial infarction","volume":"6","author":"Jia","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.coph.2020.06.007_bib0170","doi-asserted-by":"crossref","first-page":"H445","DOI":"10.1152\/ajpheart.00338.2016","article-title":"Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction","volume":"311","author":"Daniel","year":"2016","journal-title":"Am J Physiol - Heart Circ Physiol"},{"key":"10.1016\/j.coph.2020.06.007_sbref0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia-and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.coph.2020.06.007_bib0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"Cardiac fibrosis \u2013 a short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.coph.2020.06.007_bib0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.coph.2020.06.007_bib0190","first-page":"2981","article-title":"Ventricular remodeling after myocardial infarction pathophysiology and therapy clinical cardiology","volume":"101","author":"St John Sutton","year":"2000","journal-title":"New Front"},{"key":"10.1016\/j.coph.2020.06.007_bib0195","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.lfs.2013.04.001","article-title":"Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox","volume":"92","author":"Costa","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.coph.2020.06.007_bib0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.yjmcc.2014.05.001","article-title":"Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells","volume":"74","author":"Wang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.coph.2020.06.007_bib0205","first-page":"E70","article-title":"Impaired insulin secretion in a mouse model of ataxia telangiectasia","volume":"293","author":"Miles","year":"2007","journal-title":"Am J Physiol Metab"},{"key":"10.1016\/j.coph.2020.06.007_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3634948","article-title":"Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders","volume":"2016","author":"Janus","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.coph.2020.06.007_bib0215","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/1873-3468.12297","article-title":"Signaling pathways involved in cardiac energy metabolism","volume":"590","author":"Chanda","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1016\/j.coph.2020.06.007_bib0220","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"281","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2020.06.007_sbref0225","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.coph.2020.06.007_bib0230","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1093\/eurheartj\/ehy596","article-title":"Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the translational research committee of the heart failure association-European society of cardiology","volume":"39","author":"Maack","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2020.06.007_bib0235","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coph.2020.06.007_bib0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/j.2040-4603.2016.tb00680.x","article-title":"Glucose transporters in cardiac metabolism and hypertrophy overview of glucose transporter","volume":"6","author":"Shao","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.coph.2020.06.007_bib0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng.735","article-title":"Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes","volume":"43","author":"Zhou","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2020.06.007_bib0250","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.110.218966","article-title":"DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome","volume":"107","author":"Mercer","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2020.06.007_bib0255","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1194\/jlr.M400430-JLR200","article-title":"Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice","volume":"46","author":"Wu","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.coph.2020.06.007_bib0260","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.freeradbiomed.2011.11.026","article-title":"The mitochondria-targeted antioxidant mitoQ decreases features of the metabolic syndrome in ATM +\/-\/ApoE -\/- mice","volume":"52","author":"Mercer","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.coph.2020.06.007_bib0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/cvr\/cvs291","article-title":"Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes","volume":"97","author":"Katare","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.coph.2020.06.007_bib0270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-409X(98)00071-4","article-title":"Pathogenesis of non-insulin-dependent (type II) diabetes mellitus (niddm) - genetic predisposition and metabolic abnormalities","volume":"35","author":"Jun","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.coph.2020.06.007_bib0275","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/dme.13037","article-title":"Recessive mutations in the cancer gene ataxia telangiectasia mutated (ATM), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistance","volume":"33","author":"Connelly","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.coph.2020.06.007_bib0280","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.4161\/cc.9.14.12253","article-title":"Cell cycle loss of ATM positively regulates the expression of hypoxia inducible factor 1 (HIF-1) through oxidative stress: role in the physiopathology of the disease","volume":"9","author":"Ousset","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.coph.2020.06.007_bib0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066027","article-title":"ATM and glut1-S490 phosphorylation regulate glut1 mediated transport in skeletal muscle","volume":"8","author":"Andrisse","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2020.06.007_bib0290","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molmet.2016.12.001","article-title":"JNK at the crossroad of obesity, insulin resistance, and cell stress response","volume":"6","author":"Solinas","year":"2017","journal-title":"Mol Metab Metab"},{"key":"10.1016\/j.coph.2020.06.007_bib0295","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-019-0456-4","article-title":"Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness","volume":"11","author":"McGill","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.coph.2020.06.007_bib0300","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cmet.2006.10.002","article-title":"ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome","volume":"4","author":"Schneider","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.coph.2020.06.007_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2015.12.009","article-title":"ATM kinase: much more than a DNA damage responsive protein","volume":"39","author":"Guleria","year":"2016","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.coph.2020.06.007_bib0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122001","article-title":"The role of erk1\/2 in the development of diabetic cardiomyopathy","volume":"17","author":"Xu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2020.06.007_bib0315","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bcp.2011.11.018","article-title":"Modulation of AT-1R\/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (spontaneous diabetic torii) rats","volume":"83","author":"Lakshmanan","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2020.06.007_bib0320","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1152\/ajpendo.00445.2015","article-title":"Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes","volume":"310","author":"Ozaki","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.coph.2020.06.007_bib0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122001","article-title":"The role of ERK1\/2 in the development of diabetic cardiomyopathy","volume":"17","author":"Xu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2020.06.007_bib0330","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/stem.125","article-title":"Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling","volume":"27","author":"Kim","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.coph.2020.06.007_bib0335","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.celrep.2015.01.027","article-title":"ATM regulates adipocyte differentiation and contributes to glucose homeostasis","volume":"10","author":"Takagi","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.coph.2020.06.007_bib0340","doi-asserted-by":"crossref","first-page":"12710","DOI":"10.1074\/jbc.M111598200","article-title":"ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53","volume":"277","author":"Tang","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489220300370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489220300370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:54:51Z","timestamp":1761461691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489220300370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":68,"alternative-id":["S1471489220300370"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2020.06.007","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure and diabetes: role of ATM","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2020.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}